» Articles » PMID: 30237150

Completeness of Reporting of Systematic Reviews of Diagnostic Test Accuracy Based on the PRISMA-DTA Reporting Guideline

Overview
Journal Clin Chem
Specialty Biochemistry
Date 2018 Sep 22
PMID 30237150
Citations 11
Authors
Affiliations
Soon will be listed here.
Abstract

Background: We evaluated the completeness of reporting of diagnostic test accuracy (DTA) systematic reviews using the recently developed Preferred Reporting Items for Systematic Reviews and MetaAnalyses (PRISMA)-DTA guidelines.

Methods: MEDLINE was searched for DTA systematic reviews published October 2017 to January 2018. The search time span was modulated to reach the desired sample size of 100 systematic reviews. Reporting on a per-item basis using PRISMA-DTA was evaluated.

Results: One hundred reviews were included. Mean reported items were 18.6 of 26 (71%; SD = 1.9) for PRISMA-DTA and 5.5 of 11 (50%; SD = 1.2) for PRISMA-DTA for abstracts. Items in the results were frequently reported. Items related to protocol registration, characteristics of included studies, results synthesis, and definitions used in data extraction were infrequently reported. Infrequently reported items from PRISMA-DTA for abstracts included funding information, strengths and limitations, characteristics of included studies, and assessment of applicability. Reporting completeness was higher in higher impact factor journals (18.9 vs 18.1 items; = 0.04), studies that cited PRISMA (18.9 vs 17.7 items; = 0.003), or used supplementary material (19.1 vs 18.0 items; = 0.004). Variability in reporting was associated with author country ( = 0.04) but not journal ( = 0.6), abstract word count limitations ( = 0.9), PRISMA adoption ( = 0.2), structured abstracts ( = 0.2), study design ( = 0.8), subspecialty area ( = 0.09), or index test ( = 0.5). Abstracts with a higher word count were more informative ( = 0.4; < 0.001). No association with word counts was observed for full-text reports ( = -0.03; = 0.06).

Conclusions: Recently published reports of DTA systematic reviews are not fully informative when evaluated against the PRISMA-DTA guidelines. These results should guide knowledge translation strategies, including journal level (e.g., PRISMA-DTA adoption, increased abstract word count, and use of supplementary material) and author level (PRISMA-DTA citation awareness) strategies.

Citing Articles

How to Critically Appraise and Interpret Systematic Reviews and Meta-Analyses of Diagnostic Accuracy: A User Guide.

Frank R, Salameh J, Islam N, Yang B, Murad M, Mustafa R Radiology. 2023; 307(3):e221437.

PMID: 36916896 PMC: 10140638. DOI: 10.1148/radiol.221437.


Prevalence of the Retro-Renal Colon: A Systematic Review and Meta-Analysis with Implications for Percutaneous Nephrolithotomy.

Kipkorir V, Cheruiyot I, Ongidi I, Nyaanga F, Neema B, Otieno E Int J Gen Med. 2022; 15:8275-8283.

PMID: 36438019 PMC: 9698329. DOI: 10.2147/IJGM.S389682.


Evaluation of Diagnostic Tests.

Barrett B, Fardy J Methods Mol Biol. 2021; 2249:319-333.

PMID: 33871852 DOI: 10.1007/978-1-0716-1138-8_18.


PRISMA-DTA for Abstracts: a new addition to the toolbox for test accuracy research.

Korevaar D, Bossuyt P, McInnes M, Cohen J Diagn Progn Res. 2021; 5(1):8.

PMID: 33795016 PMC: 8017829. DOI: 10.1186/s41512-021-00097-4.


Preferred reporting items for journal and conference abstracts of systematic reviews and meta-analyses of diagnostic test accuracy studies (PRISMA-DTA for Abstracts): checklist, explanation, and elaboration.

Cohen J, Deeks J, Hooft L, Salameh J, Korevaar D, Gatsonis C BMJ. 2021; 372:n265.

PMID: 33722791 PMC: 7957862. DOI: 10.1136/bmj.n265.